Solutions for a Better Tomorrow

The Current Challenges

The existing flow cytometers face challenges such as being bulky, complex in both mechanical and optical systems, high in cost and predominantly controlled by foreign brands, rendering them inaccessible to primary medical institutions. Addressing the localization of high-end medical equipment and the affordability of healthcare for the general populace has become a pressing issue.

Our Innovation and Breakthrough

Our innovative microfluidic flow cytometry-based cell-molecular analyser introduces several advancements:

• Utilization of the exclusive MSTS-Transfer^TM Technology enables multi-parameter measurement with a single laser, streamlining the process.
• Significantly reduced sample volume and detection time compared to traditional flow cytometers contribute to cost-effectiveness, compactness, and convenience of our device.
• By circumventing the large size, intricate mechanical and optical systems, and high costs associated with traditional flow cytometers, our analyser finds extensive application in the detection of cells, proteins, and nucleic acids in biological samples.

The Impact

The incorporation of the proprietary MSTS-Transfer^TM Technology offers substantial benefits:

• Measurement with a single laser capable of detecting 4 colours enables the analysis of 96+ parameters, leading to a notable reduction in instrument costs.
• Integration of microfluidic chip technology effectively reduces the overall size of the instrument.
• Implementation of AI image analysis technology enhances the intelligence of image analysis processes.
• Fusion of flow cytometry, PCR, immunoassay kit, and instrument functionalities into one device expands its utility.
• The compact, convenient and intelligent design of the instrument transforms it into an affordable and portable diagnostic device, facilitating its wider adoption in healthcare settings.